Literature DB >> 22728849

Sensory neurons, ion channels, inflammation and the onset of neuropathic pain.

Patrick L Stemkowski1, Peter A Smith.   

Abstract

Neuropathic pain often fails to respond to conventional pain management procedures. here we review the aetiology of neuropathic pain as would result from peripheral neuropathy or injury. We show that inflammatory mediators released from damaged nerves and tissue are responsible for triggering ectopic activity in primary afferents and that this, in turn, provokes increased spinal cord activity and the development of 'central sensitization'. Although evidence is mounting to support the role of interleukin-1β, prostaglandins and other cytokines in the onset of neuropathic pain, the clinical efficacy of drugs which antagonize or prevent the actions of these mediators is yet to be determined. basic science findings do, however, support the use of pre-emptive analgesia during procedures which involve nerve manipulation and the use of anti-inflammatory steroids as soon as possible following traumatic nerve injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728849     DOI: 10.1017/s0317167100013937

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  19 in total

Review 1.  Therapeutic Strategies to Treat Dry Eye in an Aging Population.

Authors:  Nisreen S Ezuddin; Karam A Alawa; Anat Galor
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

Review 2.  Stress-induced pain: a target for the development of novel therapeutics.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld
Journal:  J Pharmacol Exp Ther       Date:  2014-09-05       Impact factor: 4.030

Review 3.  The impact of inflammation on respiratory plasticity.

Authors:  Austin D Hocker; Jennifer A Stokes; Frank L Powell; Adrianne G Huxtable
Journal:  Exp Neurol       Date:  2016-07-27       Impact factor: 5.330

4.  Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1β exposure is K(+) channel dependent and reversible.

Authors:  Patrick L Stemkowski; Myung-Chul Noh; Yishen Chen; Peter A Smith
Journal:  J Physiol       Date:  2015-07-26       Impact factor: 5.182

5.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

6.  Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.

Authors:  Z-Y Wang; T McDowell; P Wang; R Alvarez; T Gomez; D E Bjorling
Journal:  Neuroscience       Date:  2014-08-01       Impact factor: 3.590

Review 7.  Psychological stress as a modulator of functional recovery following spinal cord injury.

Authors:  Sioui Maldonado Bouchard; Michelle A Hook
Journal:  Front Neurol       Date:  2014-04-09       Impact factor: 4.003

8.  Diabetes impairs an interleukin-1β-dependent pathway that enhances neurite outgrowth through JAK/STAT3 modulation of mitochondrial bioenergetics in adult sensory neurons.

Authors:  Ali Saleh; Subir K Roy Chowdhury; Darrell R Smith; Savitha Balakrishnan; Lori Tessler; Emily Schartner; Andre Bilodeau; Randy Van Der Ploeg; Paul Fernyhough
Journal:  Mol Brain       Date:  2013-10-24       Impact factor: 4.041

9.  Adjuvant use of melatonin for relieving symptoms of painful diabetic neuropathy: results of a randomized, double-blinded, controlled trial.

Authors:  Maryam Shokri; Firozeh Sajedi; Younes Mohammadi; Maryam Mehrpooya
Journal:  Eur J Clin Pharmacol       Date:  2021-06-13       Impact factor: 2.953

10.  Voltage-gated potassium channel dysfunction in dorsal root ganglia contributes to the exaggerated exercise pressor reflex in rats with chronic heart failure.

Authors:  Juan Hong; Shubin Fu; Lie Gao; Yanhui Cai; Eric Lazartigues; Han-Jun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-07-16       Impact factor: 5.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.